Delivery Order SPE2DB20D3103-SPE2DB24FM0N8

Award Date 12/26/23
Potential Completion Date 12/27/23
Potential Value $7.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM to the Defense Logistics Agency (DLA). The $1,507.46 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 9, 2024 with a completion date of December 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $4,461.37 and a completion date of January 12, 2024. It is not associated with a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $2,004.05 and a completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $1,642.32. This is a firm fixed price delivery order contract with a completion date of June 14, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, on April 2, 2024 as a firm fixed price delivery order under an existing indefinite delivery contract (IDC) with a potential value of up to...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,066.90 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 6, 2025 with a completion date of March 7, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,617.86 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The contract is not designated as a set-aside and is part of a larger...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. The contract has a ceiling value of $13,022.30 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation....
This federal contract award is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,527.07, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 27, 2023 with a completion date of December 28, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers to the Defense Logistics Agency (DLA). The $2,211.56 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with a completion date of November 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM0N8
    Delivery Order

This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $7,492.44 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 26, 2023 with a completion date of December 27, 2023.

The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs globally.

Generated 5/13/25, 10:17 AM